MARKET

ALPMY

ALPMY

Astellas Pharma
OTCPK
14.99
-0.14
-0.93%
Closed 15:45 08/20 EDT
OPEN
15.09
PREV CLOSE
15.13
HIGH
15.10
LOW
14.99
VOLUME
15.71K
TURNOVER
236.25K
52 WEEK HIGH
16.96
52 WEEK LOW
10.05
MARKET CAP
26.88B
P/E (TTM)
11.87
1D
5D
1M
3M
1Y
5Y
1D
Astellas Pharma (ALPMF) Receives a Buy from CLSA
TipRanks · 3d ago
Weekly Report: what happened at ALPMY last week (0810-0814)?
Weekly Report · 4d ago
Weekly Report: what happened at ALPMY last week (0803-0807)?
Weekly Report · 08/10 09:23
Goldman Sachs Remains a Buy on Astellas Pharma (ALPMF)
TipRanks · 08/06 10:17
Astellas Pharma (ALPMF) Receives a Hold from Morgan Stanley
TipRanks · 08/06 10:16
Astellas Pharma ADR GAAP EPS of ¥78.96, revenue of ¥640.91B; reaffirms FY 2027 outlook
Seeking Alpha · 08/05 06:38
Weekly Report: what happened at ALPMY last week (0727-0731)?
Weekly Report · 08/03 09:23
Astellas Pharma (ALPMF) Receives a Hold from SBI Securities
TipRanks · 07/29 11:15
More
About ALPMY
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Webull offers Astellas Pharma Inc stock information, including OTCPK: ALPMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALPMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALPMY stock methods without spending real money on the virtual paper trading platform.